Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 105

    1.

    Vasopressin Type 2 Receptor V88M Mutation: Molecular Basis of Partial and Complete Nephrogenic Diabetes Insipidus.

    Bockenhauer D, Carpentier E, Rochdi D, Van't Hoff W, Breton B, Bernier V, Bouvier M, Bichet DG.

    Nephron Physiol. 2009 Oct 8;114(1):p1-p10. [Epub ahead of print]PMID: 19816050 [PubMed - as supplied by publisher]Related articles

    2.

    Characterization of D150E and G196D aquaporin-2 mutations responsible for nephrogenic diabetes insipidus: importance of a mild phenotype.

    Guyon C, Lussier Y, Bissonnette P, Leduc-Nadeau A, Lonergan M, Arthus MF, Perez RB, Tiulpakov A, Lapointe JY, Bichet DG.

    Am J Physiol Renal Physiol. 2009 Aug;297(2):F489-98. Epub 2009 May 20.PMID: 19458121 [PubMed - indexed for MEDLINE]Related articles

    3.

    Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus.

    El-Kares R, Hueber PA, Blumenkrantz M, Iglesias D, Ma K, Jabado N, Bichet DG, Goodyer P.

    Pediatr Nephrol. 2009 Jul;24(7):1313-9. Epub 2009 Mar 18.PMID: 19294427 [PubMed - indexed for MEDLINE]Related articles

    4.

    Ethnic differences in renal responses to furosemide.

    Chun TY, Bankir L, Eckert GJ, Bichet DG, Saha C, Zaidi SA, Wagner MA, Pratt JH.

    Hypertension. 2008 Aug;52(2):241-8. Epub 2008 Jul 7.PMID: 18606909 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists.

    Perucca J, Bichet DG, Bardoux P, Bouby N, Bankir L.

    J Am Soc Nephrol. 2008 Sep;19(9):1721-31. Epub 2008 Jul 2.PMID: 18596120 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Vasopressin receptor mutations in nephrogenic diabetes insipidus.

    Bichet DG.

    Semin Nephrol. 2008 May;28(3):245-51. Review.PMID: 18519085 [PubMed - indexed for MEDLINE]Related articles

    7.

    Urinary globotriaosylceramide excretion correlates with the genotype in children and adults with Fabry disease.

    Auray-Blais C, Cyr D, Ntwari A, West ML, Cox-Brinkman J, Bichet DG, Germain DP, Laframboise R, Melançon SB, Stockley T, Clarke JT, Drouin R.

    Mol Genet Metab. 2008 Mar;93(3):331-40. Epub 2007 Nov 26.PMID: 18023222 [PubMed - indexed for MEDLINE]Related articles

    8.

    Expression and functionality of the Na+/myo-inositol cotransporter SMIT2 in rabbit kidney.

    Lahjouji K, Aouameur R, Bissonnette P, Coady MJ, Bichet DG, Lapointe JY.

    Biochim Biophys Acta. 2007 May;1768(5):1154-9. Epub 2007 Jan 19.PMID: 17306760 [PubMed - indexed for MEDLINE]Related articles

    9.

    Agalsidase-beta therapy for advanced Fabry disease: a randomized trial.

    Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M, Finkel R, Packman S, Bichet DG, Warnock DG, Desnick RJ; Fabry Disease Clinical Trial Study Group.

    Ann Intern Med. 2007 Jan 16;146(2):77-86. Epub 2006 Dec 18.PMID: 17179052 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    [Nephrogenic diabetes insipidus]

    Bichet DG.

    Nephrol Ther. 2006 Nov;2(6):387-404. Epub 2006 Sep 25. Review. French. PMID: 17081961 [PubMed - indexed for MEDLINE]Related articles

    11.

    Elaboration of a novel technique for purification of plasma membranes from Xenopus laevis oocytes.

    Leduc-Nadeau A, Lahjouji K, Bissonnette P, Lapointe JY, Bichet DG.

    Am J Physiol Cell Physiol. 2007 Mar;292(3):C1132-6. Epub 2006 Nov 1.PMID: 17079335 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The role of the GX9GX3G motif in the gating of high voltage-activated Ca2+ channels.

    Raybaud A, Dodier Y, Bissonnette P, Simoes M, Bichet DG, Sauvé R, Parent L.

    J Biol Chem. 2006 Dec 22;281(51):39424-36. Epub 2006 Oct 11.PMID: 17038321 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Severe combined immunodeficiency associated with nephrogenic diabetes insipidus and a deletion in the Xq28 region.

    Broides A, Ault BH, Arthus MF, Bichet DG, Conley ME.

    Clin Immunol. 2006 Aug;120(2):147-55. Epub 2006 Jun 15.PMID: 16781893 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hereditary polyuric disorders: new concepts and differential diagnosis.

    Bichet DG.

    Semin Nephrol. 2006 May;26(3):224-33. Review.PMID: 16713495 [PubMed - indexed for MEDLINE]Related articles

    15.

    Nephrogenic diabetes insipidus.

    Bichet DG.

    Adv Chronic Kidney Dis. 2006 Apr;13(2):96-104. Review.PMID: 16580609 [PubMed - indexed for MEDLINE]Related articles

    16.

    Lithium, cyclic AMP signaling, A-kinase anchoring proteins, and aquaporin-2.

    Bichet DG.

    J Am Soc Nephrol. 2006 Apr;17(4):920-2. Epub 2006 Mar 15. Review. No abstract available. PMID: 16540556 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Nephrogenic diabetes insipidus.

    Sands JM, Bichet DG; American College of Physicians; American Physiological Society.

    Ann Intern Med. 2006 Feb 7;144(3):186-94. Review. No abstract available. PMID: 16461963 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.

    Bernier V, Morello JP, Zarruk A, Debrand N, Salahpour A, Lonergan M, Arthus MF, Laperrière A, Brouard R, Bouvier M, Bichet DG.

    J Am Soc Nephrol. 2006 Jan;17(1):232-43. Epub 2005 Nov 30. Erratum in: J Am Soc Nephrol. 2006 Feb;17(2):591. Dosage error in article text. PMID: 16319185 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Molecular biology of hereditary diabetes insipidus.

    Fujiwara TM, Bichet DG.

    J Am Soc Nephrol. 2005 Oct;16(10):2836-46. Epub 2005 Aug 10. Review.PMID: 16093448 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans.

    Bankir L, Fernandes S, Bardoux P, Bouby N, Bichet DG.

    J Am Soc Nephrol. 2005 Jul;16(7):1920-8. Epub 2005 May 11.PMID: 15888562 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    The dilemma of diagnosing the cause of hypernatraemia: drinking habits vs diabetes insipidus.

    Workeneh B, Balakumaran A, Bichet DG, Mitch WE.

    Nephrol Dial Transplant. 2004 Dec;19(12):3165-7. No abstract available. PMID: 15575005 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L.

    de Mattia F, Savelkoul PJ, Bichet DG, Kamsteeg EJ, Konings IB, Marr N, Arthus MF, Lonergan M, van Os CH, van der Sluijs P, Robertson G, Deen PM.

    Hum Mol Genet. 2004 Dec 15;13(24):3045-56. Epub 2004 Oct 27.PMID: 15509592 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Pharmacological chaperone action on G-protein-coupled receptors.

    Bernier V, Bichet DG, Bouvier M.

    Curr Opin Pharmacol. 2004 Oct;4(5):528-33. Review.PMID: 15351360 [PubMed - indexed for MEDLINE]Related articles

    24.

    The quest for the gene responsible for medullary cystic kidney disease type 1.

    Bichet DG, Fujiwara TM.

    Kidney Int. 2004 Aug;66(2):864-5. Review. No abstract available. PMID: 15253745 [PubMed - indexed for MEDLINE]Related articles

    25.

    Pharmacological chaperones: potential treatment for conformational diseases.

    Bernier V, Lagacé M, Bichet DG, Bouvier M.

    Trends Endocrinol Metab. 2004 Jul;15(5):222-8. Review.PMID: 15223052 [PubMed - indexed for MEDLINE]Related articles

    26.

    Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059.

    Bernier V, Lagacé M, Lonergan M, Arthus MF, Bichet DG, Bouvier M.

    Mol Endocrinol. 2004 Aug;18(8):2074-84. Epub 2004 May 27.PMID: 15166253 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Reabsorption of sodium chloride--lessons from the chloride channels.

    Bichet DG, Fujiwara TM.

    N Engl J Med. 2004 Mar 25;350(13):1281-3. No abstract available. PMID: 15044637 [PubMed - indexed for MEDLINE]Related articles

    28.

    [Nobel Prize for Chemistry 2003. Water channels and ionic channels]

    Bichet DG, Parent L, Sauvé R.

    Med Sci (Paris). 2003 Dec;19(12):1289-90. French. No abstract available. PMID: 14691755 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Reversed polarized delivery of an aquaporin-2 mutant causes dominant nephrogenic diabetes insipidus.

    Kamsteeg EJ, Bichet DG, Konings IB, Nivet H, Lonergan M, Arthus MF, van Os CH, Deen PM.

    J Cell Biol. 2003 Dec 8;163(5):1099-109.PMID: 14662748 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Influence of plasma amino acid level on vasopressin secretion.

    Schmitt F, Bresson JL, Beressi N, Bichet DG, Chauveau D, Bankir L.

    Diabetes Metab. 2003 Sep;29(4 Pt 1):352-61.PMID: 14526263 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system.

    Bardoux P, Bichet DG, Martin H, Gallois Y, Marre M, Arthus MF, Lonergan M, Ruel N, Bouby N, Bankir L.

    Nephrol Dial Transplant. 2003 Mar;18(3):497-506.PMID: 12584270 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Cell-biologic and functional analyses of five new Aquaporin-2 missense mutations that cause recessive nephrogenic diabetes insipidus.

    Marr N, Bichet DG, Hoefs S, Savelkoul PJ, Konings IB, De Mattia F, Graat MP, Arthus MF, Lonergan M, Fujiwara TM, Knoers NV, Landau D, Balfe WJ, Oksche A, Rosenthal W, Müller D, Van Os CH, Deen PM.

    J Am Soc Nephrol. 2002 Sep;13(9):2267-77.PMID: 12191971 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Two novel aquaporin-2 mutations responsible for congenital nephrogenic diabetes insipidus in Chinese families.

    Lin SH, Bichet DG, Sasaki S, Kuwahara M, Arthus MF, Lonergan M, Lin YF.

    J Clin Endocrinol Metab. 2002 Jun;87(6):2694-700.PMID: 12050236 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Heteroligomerization of an Aquaporin-2 mutant with wild-type Aquaporin-2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus.

    Marr N, Bichet DG, Lonergan M, Arthus MF, Jeck N, Seyberth HW, Rosenthal W, van Os CH, Oksche A, Deen PM.

    Hum Mol Genet. 2002 Apr 1;11(7):779-89.PMID: 11929850 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Intrafamilial phenotype variability in nephrogenic diabetes insipidus.

    Kalenga K, Persu A, Goffin E, Lavenne-Pardonge E, van Cangh PJ, Bichet DG, Devuyst O.

    Am J Kidney Dis. 2002 Apr;39(4):737-43.PMID: 11920339 [PubMed - indexed for MEDLINE]Related articles

    36.

    Body compartment volumes and composition after giving a vasopressin antagonist: changes are revealed by a tonicity balance.

    Davids MR, Edoute Y, Mallie JP, Bichet DG, Halperin ML.

    Nephrol Dial Transplant. 2002 Feb;17(2):300-3. No abstract available. PMID: 11812887 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Integrative physiology of basal water permeability in the distal nephron: implications for the syndrome of inappropriate secretion of antidiuretic hormone.

    Halperin ML, Bichet DG, Oh MS.

    Clin Nephrol. 2001 Nov;56(5):339-45. Review.PMID: 11758003 [PubMed - indexed for MEDLINE]Related articles

    38.

    Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminus.

    Kuwahara M, Iwai K, Ooeda T, Igarashi T, Ogawa E, Katsushima Y, Shinbo I, Uchida S, Terada Y, Arthus MF, Lonergan M, Fujiwara TM, Bichet DG, Marumo F, Sasaki S.

    Am J Hum Genet. 2001 Oct;69(4):738-48. Epub 2001 Aug 30.PMID: 11536078 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus.

    Morello JP, Salahpour A, Petäjä-Repo UE, Laperrière A, Lonergan M, Arthus MF, Nabi IR, Bichet DG, Bouvier M.

    Biochemistry. 2001 Jun 12;40(23):6766-75.PMID: 11389590 [PubMed - indexed for MEDLINE]Related articles

    40.

    A patient with partial central diabetes insipidus: clarifying pathophysiology and designing treatment.

    Kamel KS, Bichet DG, Halperin ML.

    Am J Kidney Dis. 2001 Jun;37(6):1290-3.PMID: 11382701 [PubMed - indexed for MEDLINE]Related articles

    41.

    Nephrogenic diabetes insipidus.

    Morello JP, Bichet DG.

    Annu Rev Physiol. 2001;63:607-30. Review.PMID: 11181969 [PubMed - indexed for MEDLINE]Related articles

    42.

    Consequences of aquaporin 2 tetramerization for genetics and routing.

    Kamsteeg EJ, Mulders SM, Bichet DG, Deen PM, van Os C.

    Nephrol Dial Transplant. 2000;15 Suppl 6:26-8. No abstract available. PMID: 11143979 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Pharmacological chaperones: a new twist on receptor folding.

    Morello JP, Petäjä-Repo UE, Bichet DG, Bouvier M.

    Trends Pharmacol Sci. 2000 Dec;21(12):466-9. Review.PMID: 11121835 [PubMed - indexed for MEDLINE]Related articles

    44.

    Dose response of arginine vasopressin to the CCK-B agonist pentagastrin.

    Abelson JL, Le Mellédo J, Bichet DG.

    Neuropsychopharmacology. 2001 Feb;24(2):161-9.PMID: 11120398 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus.

    Arthus MF, Lonergan M, Crumley MJ, Naumova AK, Morin D, De Marco LA, Kaplan BS, Robertson GL, Sasaki S, Morgan K, Bichet DG, Fujiwara TM.

    J Am Soc Nephrol. 2000 Jun;11(6):1044-54.PMID: 10820168 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.

    Morello JP, Salahpour A, Laperrière A, Bernier V, Arthus MF, Lonergan M, Petäjä-Repo U, Angers S, Morin D, Bichet DG, Bouvier M.

    J Clin Invest. 2000 Apr;105(7):887-95.PMID: 10749568 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    The relationship among carbon dioxide pneumoperitoneum, vasopressin release, and hemodynamic changes.

    Mann C, Boccara G, Pouzeratte Y, Eliet J, Serradel-Le Gal C, Vergnes C, Bichet DG, Guillon G, Fabre JM, Colson P.

    Anesth Analg. 1999 Aug;89(2):278-83.PMID: 10439730 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    [Hyponatremia, toward a logical approach: the balance of tonicity]

    Mallié JP, Halperin ML, Bichet DG.

    Nephrologie. 1998;19(8):469-80. Review. French. Erratum in: Nephrologie 1999;20(1):51. PMID: 9894640 [PubMed - indexed for MEDLINE]Related articles

    49.

    Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases.

    Le Mellédo JM, Merani S, Koszycki D, Bellavance F, Palmour R, Gutkowska J, Steinberg S, Bichet DG, Bradwejn J.

    Neuropsychopharmacology. 1999 Jan;20(1):81-91.PMID: 9885787 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Nephrogenic diabetes insipidus.

    Bichet DG.

    Am J Med. 1998 Nov;105(5):431-42. Review.PMID: 9831428 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...